Krüppel‐like factor 4 promotes c‐Met amplification‐mediated gefitinib resistance in non‐small‐cell lung cancer

Podobne zapisy

• Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification
  od: Jang, Won-Jun, i wsp.
  Wydane: (2014)
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
  od: Bean, James, i wsp.
  Wydane: (2007)
• Opposing effects of Krüppel-like factor 4 (gut-enriched Krüppel-like factor) and Krüppel-like factor 5 (intestinal-enriched Krüppel-like factor) on the promoter of the Krüppel-like factor 4 gene
  od: Dang, Duyen T., i wsp.
  Wydane: (2002)
• Successful treatment of lung adenocarcinoma with gefitinib based on EGFR gene amplification
  od: Wang, Chunguo, i wsp.
  Wydane: (2018)
• Deletion of Krüppel-like factor-4 promotes axonal regeneration in mammals
  od: Xu, Jin-Hui, i wsp.
  Wydane: (2020)